Conditions and Diseases > FDA News > FDA Press Releases and Papers - Medical Information - Diseases

Disease Condition

FDA Press Releases and Papers

Press releases and Talk Papers from FDA

Listings

There are 5 listings in this category.

Press Release 2

FDA Approves First Drug for Treatment of Chorea in Huntington's Disease The U.S. Food and Drug Administration has approved Xenazine (tetrabenazine) for the treatment of chorea in people with Huntington's disease. Chorea is the jerky, involuntary movement that occurs in people with this disease.

(Hits: 229 | Votes: 0 | Visited: 0 | Added: 2005-05-16 20:32:04)

Press Release 1

FDA Warns Consumers Not to Eat Certain Mussel Products from Bantry Bay Seafood (August 15) The U.S. Food and Drug Administration (FDA) is warning consumers against eating certain frozen cooked mussel products made by Bantry Bay Seafoods, imported from Ireland, because they may be contaminated with azaspiracid toxins, a group of naturally occurring marine toxins known to cause nausea, vomiting, diarrhea, and stomach cramps.

(Hits: 199 | Votes: 0 | Visited: 0 | Added: 2005-05-16 20:26:03)

Press Release 4

FDA Approves 2008-2009 Flu Vaccines The U.S. Food and Drug Administration (FDA) today announced that it has approved this year's seasonal influenza vaccines that include new strains of the virus likely to cause flu in the United States during the 2008-2009 season. The six vaccines and their manufacturers are: CSL Limited, Afluria; GlaxoSmithKline Biologicals, Fluarix; ID Biomedical Corporation of Quebec, FluLaval; MedImmune Vaccines Inc., FluMist; Novartis Vaccines and Diagnostics Limited, Fluvirin; and Sanofi Pasteur Inc., Fluzone.

(Hits: 189 | Votes: 0 | Visited: 0 | Added: 2005-05-16 20:32:30)

Press Release 3

FDA Warns Consumers About Potential Problems at Two Baltimore Pharmacies The U.S. Food and Drug Administration is warning consumers who filled prescriptions at The Medicine Shoppe pharmacies located at 8035A Liberty Road and 5900 Reisterstown Road in Baltimore that they may have received drugs that were either expired or suspected counterfeit. The FDA is particularly concerned because a number of the drugs are for serious diseases and could have an adverse effect on treatment.

(Hits: 178 | Votes: 0 | Visited: 0 | Added: 2005-05-16 20:32:17)

Press Release 5

FDA Announces Improved Policies Regarding Transparency, Public Disclosure for Advisory Committees The Food and Drug Administration today announced several improved policies and procedures strengthening its management of FDA advisory committees. The improvements include stricter limits on financial conflicts of interest for committee members, improved voting procedures, and improvements to the processes for disclosing information pertaining both to advisory committee members and to specific matters considered at advisory committee meetings.

(Hits: 176 | Votes: 0 | Visited: 0 | Added: 2005-05-16 20:32:46)

Results 1 - 5 of 5
<< Start < Prev 1 Next > End >>